Heterozygosity of SNP513 in intron 9 of the human calretinin gene (CALB2) is a risk factor for colon cancer

Anticancer Res. 2007 Nov-Dec;27(6C):4279-88.

Abstract

Background: The Ca2+-binding protein calretinin (CR), while absent in normal colonocytes, is expressed in the majority of poorly differentiated colon carcinomas, and is hypothesized that mutations in the distal part (from exon 7 to 10) of the CR gene (CALB2) could be responsible for the aberrant CR expression.

Materials and methods: Using PCR amplification of genomic DNA and restriction fragment length polymorphism analysis, four single nucleotide polymorphisms (SNPs) were identified in CALB2 intron 9.

Results: A significant positive association between the genotype at SNP513 and colon cancer was found: more C/T heterozygotes were found in patients with colon tumors (60%) compared to healthy controls (35%) or patients with lung tumors (38%). Our results indicate that C/T heterozygosity at position 513 is linked to CR expression in colon tumors and colon cancer cell lines, suggesting a link with increased carcinogenesis.

Conclusion: The SNP513 in human CALB2 may thus be a predictive marker for colon tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Base Sequence
  • Biomarkers, Tumor* / genetics
  • Blotting, Western
  • Calbindin 2
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology
  • Genetic Predisposition to Disease
  • Heterozygote
  • Humans
  • Introns
  • Middle Aged
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Risk Factors
  • S100 Calcium Binding Protein G / genetics*

Substances

  • Biomarkers, Tumor
  • CALB2 protein, human
  • Calbindin 2
  • S100 Calcium Binding Protein G